Altria (MO) Q2 2026 Earnings
How Did MO Stock React to Q2 2026 Earnings?
S&P 500 over the same 30 days: +3.42%.
Did MO Beat Earnings? Q2 2026 Results
No. Altria reported Q2 2026 earnings of $1.48 a share on Jul 30, 2026, missing the $1.50 consensus estimate by 1.2%. Revenue was $5.4B against a $5.3B estimate.
Altria delivered a mixed second quarter for 2026, narrowly missing the Wall Street earnings target while posting modest revenue growth that keeps the tobacco giant's cautious turnaround narrative intact. Adjusted diluted EPS came in at $1.48, falling just short of the $1.50 consensus by 1.18%, as elevated special items including $88 million in USSTC facilities consolidation charges and $95 million in litigation costs weighed on reported results. Revenue of $5.36 billion edged past estimates by 0.15%, rising 1.3% year over year, supported by pricing strength in the smokeable products segment even as domestic cigarette shipment volumes fell 3.2% on a reported basis, reflecting both the industry's secular decline and consumer downtrading toward discount brands. The oral tobacco segment remained a drag, with Marlboro's retail share slipping 1.5 points to 39.5% and nicotine pouches continuing to reshape the competitive landscape, a trend rivals are increasingly exploiting. Altria narrowed its full-year 2026 adjusted EPS guidance to $5.61 to $5.72, raising the lower end, as it bets on smoke-free portfolio expansion and second-half import and export benefits to sustain momentum.
- Higher pricing in smokeable products offset by lower shipment volume and higher promotional investments
- Higher refunds of taxes and duties on imported cigarettes benefiting smokeable OCI
- Contract manufactured export cigarette volume surged 54.9% in Q2
- Fewer shares outstanding contributing to adjusted diluted EPS growth
- Lower adjusted effective tax rate (23.0% vs 23.3%)
- Basic brand gaining traction in discount cigarette segment
- Cigar shipment volume increased 5.0% in Q2
“In the second quarter, our operating companies continued to deliver against the priorities we outlined at the start of the year – advancing our smoke-free portfolio, strengthening our traditional tobacco businesses and delivering significant returns to shareholders.”
Altria CEO, on the earnings call
What Is Altria's Outlook?
Altria narrowed its 2026 full-year adjusted diluted EPS guidance to a range of $5.61 to $5.72, representing 3.5% to 5.5% growth from a 2025 base of $5.42. The lower end was raised from prior guidance. The company expects a greater benefit from cigarette import and export activity in the second half, with that benefit more balanced between Q3 and Q4. Capital expenditure guidance was increased to $375 million–$450 million (from $300M–$375M) primarily to support USSTC manufacturing consolidation. Guidance contemplates: moderated e-vapor industry growth affecting combustible and e-vapor volumes, increased macroeconomic uncertainty, investments in contract manufacturing capabilities, NJOY ACE not returning to market in 2026, reinvestment of Optimize & Accelerate initiative cost savings, and investments supporting the company's Vision strategy.
MO YoY Financials
| Metric | Q2 2026 | Q2 2025 | Year over year |
|---|---|---|---|
| Revenue | $5.4B | $5.3B | +1.3% |
| Gross Profit | $3.8B | $3.9B | −0.8% |
| Operating Income | $3.1B | $3.2B | −2.9% |
| Net Income | $2.3B | $2.4B | −3.4% |
MO Revenue by Segment
When Does Altria Report Next?
Figures from SEC filings and company reports. Not investment advice.